公司概述
INLIF Limited specializes in the research, development, manufacture, and sale of injection molding machine-dedicated manipulator arms operating under its iNLIF brand within the People's Republic of China. The company functions within the Industrials sector, specifically the Specialty Industrial Machinery industry, which involves the production of specialized equipment tailored for specific manufacturing processes rather than general-purpose machinery. Its operational scale is defined by a market capitalization of $54.12M, annual revenue of $18.41M, and an employee count of 156. These valuation and revenue figures indicate that INLIF Limited operates as a micro-cap entity with a relatively small market footprint, suggesting limited diversification and a reliance on niche market dynamics within the Chinese industrial automation landscape.
财务健康
The company reported revenue of $18.41M over the trailing twelve months, yet recorded a net income of $-5,446,252 and an EBITDA of $-5,489,902, revealing a significant gap between top-line generation and bottom-line profitability driven by substantial operating losses. Despite the negative earnings, the firm generated free cash flow of $1.10M, which provides a degree of financial flexibility to fund ongoing operations or reduce debt without immediate external financing. The margin profile shows a gross margin of 23.3%, indicating reasonable pricing power or cost control on the product itself, while the operating margin of -46.1% and profit margin of -29.6% highlight severe inefficiencies in overhead absorption or high general and administrative expenses. The balance sheet holds $6.72M in cash against $4.97M in debt, resulting in a debt-to-equity ratio of 30.82, which suggests a leveraged position where liabilities significantly outweigh equity capitalization. A current ratio of 2.11 indicates that the company possesses ample short-term assets to cover its short-term liabilities, signaling strong immediate liquidity despite the net income deficit. Return on Equity stands at -41.3% and Return on Assets is -16.8%, metrics that reveal management has failed to generate positive returns on the capital invested in the business over the reporting period.
估值评估
Both the trailing P/E ratio and forward P/E ratio are listed as N/A due to the company's negative earnings, meaning traditional earnings-based valuation multiples cannot be applied to assess expected earnings trajectory. The price-to-book ratio is 0.29, indicating that the stock trades at a deep discount to its book value, which often occurs in companies with significant intangible assets or those struggling to generate earnings. Alternative valuation metrics such as a price-to-sales ratio of 2.94 and an EV/EBITDA of -9.54 suggest the market is pricing the company based on sales multiples or distressed asset valuations rather than profitability expectations. The stock has fluctuated between a 52-week high of $28.00 and a 52-week low of $3.80, currently trading well below the high and reflecting the high volatility typical of small-cap industrials. The beta value is N/A, preventing a direct comparison of price volatility relative to the broader market index based on historical data provided.
Growth & Income
Revenue growth year-over-year declined by 10.2%, while earnings growth is N/A due to the company's continued losses, implying that top-line contraction has exacerbated the underlying operational challenges. As a non-dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, the company retains all earnings, though currently negative, to fund operations rather than distributing income to shareholders. The absence of dividend payments aligns with the firm's need to conserve cash given its negative net income and leveraged capital structure. Overall, the growth and income profile is characterized by negative revenue momentum, a complete lack of current profitability, and no distribution of capital to investors.